Champions Oncology Inc (CSBR)
4.76
-0.05
(-1.11%)
USD |
NASDAQ |
May 16, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Profit Margin (Quarterly): -21.05% for Jan. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -21.05% |
| October 31, 2023 | -17.90% |
| July 31, 2023 | -20.43% |
| April 30, 2023 | -19.59% |
| January 31, 2023 | -19.10% |
| October 31, 2022 | -0.11% |
| July 31, 2022 | -2.32% |
| April 30, 2022 | -2.67% |
| January 31, 2022 | 5.97% |
| October 31, 2021 | 2.35% |
| July 31, 2021 | -1.53% |
| April 30, 2021 | -6.37% |
| January 31, 2021 | 8.87% |
| October 31, 2020 | 0.01% |
| July 31, 2020 | 0.79% |
| April 30, 2020 | -24.75% |
| January 31, 2020 | 4.52% |
| October 31, 2019 | 4.03% |
| July 31, 2019 | -9.51% |
| April 30, 2019 | -3.28% |
| January 31, 2019 | -5.74% |
| October 31, 2018 | 3.99% |
| July 31, 2018 | 7.74% |
| April 30, 2018 | -12.84% |
| January 31, 2018 | -1.50% |
| Date | Value |
|---|---|
| October 31, 2017 | -1.81% |
| July 31, 2017 | -13.39% |
| April 30, 2017 | -65.16% |
| January 31, 2017 | -39.52% |
| October 31, 2016 | -11.31% |
| July 31, 2016 | -69.37% |
| April 30, 2016 | -90.73% |
| January 31, 2016 | -94.51% |
| October 31, 2015 | -85.76% |
| July 31, 2015 | -103.2% |
| April 30, 2015 | -113.5% |
| January 31, 2015 | -154.0% |
| October 31, 2014 | -163.5% |
| July 31, 2014 | -185.6% |
| April 30, 2014 | -92.43% |
| January 31, 2014 | -15.56% |
| October 31, 2013 | -97.27% |
| July 31, 2013 | -73.91% |
| April 30, 2013 | -111.1% |
| January 31, 2013 | -33.94% |
| October 31, 2012 | -135.4% |
| July 31, 2012 | -62.82% |
| April 30, 2012 | -184.6% |
| January 31, 2012 | -71.74% |
| October 31, 2011 | -134.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-24.75%
Minimum
Apr 2020
8.87%
Maximum
Jan 2021
-6.25%
Average
-2.32%
Median
Jul 2022
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -122.6% |
| Electromed Inc | 10.76% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -417.9% |
| Return on Assets | -31.29% |
| Return on Invested Capital | -417.9% |
| Gross Profit Margin (Quarterly) | 34.70% |
| Operating Margin (Quarterly) | -21.44% |
| Return on Net Operating Assets | -35.95% |